Table 1.
Baseline demographics and clinical characteristics of the individuals studied
Asympt chagasic patients | Sympt chagasic patients | Healthy controls | Non‐chagasic cardiomyopathy | |
---|---|---|---|---|
Number of individuals | 9 | 12 | 11 | 5 |
Age media (±SD) | 48.78 (±8.48) | 54.08 (±9.37) | 43.82 (±14.29) | 58.40 (±4.67) |
Female sex (%) | 66.67 | 50 | 81.82 | 40 |
Clinical assessment | ||||
ACC/AHAS classification | ||||
A No. (%) | 5 (55.56) | — | — | — |
B No. (%) | 4 (44.44) | — | — | — |
C No. (%) | — | 7 (58.33) | — | 2 (40) |
D No. (%) | — | 5 (41.67) | — | 3 (60) |
Mean LVEF (%) (±SD)* | 60 (±5.90) | 38.33 (±17.49) | — | 39 (±16.73) |
Heart failure etiology | ||||
Ischemic heart failure | — | — | — | 2 |
Hypertensive heart failure | — | — | — | 1 |
Dilated idiopathic heart failure | — | — | — | 1 |
Valvular heart failure | — | — | — | 1 |
Groups: Asympt chagasic patients: those with non‐structural cardiac damage (groups A and B). Sympt chagasic patients: those with structural cardiac damage (groups C and D). ACC/AHAS Classification: A: Normal electrocardiogram (ECG) and echocardiogram findings, and New York heart association functional classification (NYHA) I; B: abnormal ECG findings, normal ECHO and NYHA I; C: Abnormal ECG findings, increased heart size, decreased LVEF, and NYHA II or III; and D: same as class C, but NYHA IV. LVEF: left ventricular ejection fraction. *p‐value: 0.0683.